Imaging Tumor Proliferation in Breast Cancer: Current Update on Predictive Imaging Biomarkers

about

Imaging Tumor Proliferation in Breast Cancer: Current Update on Predictive Imaging Biomarkers

Item

http://www.wikidata.org/entity/Q57110625

description

scientific article published on 01 July 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2018

@uk

name

Imaging Tumor Proliferation in ...... Predictive Imaging Biomarkers

@en

Imaging Tumor Proliferation in ...... Predictive Imaging Biomarkers

@nl

type

Item

label

Imaging Tumor Proliferation in ...... Predictive Imaging Biomarkers

@en

Imaging Tumor Proliferation in ...... Predictive Imaging Biomarkers

@nl

prefLabel

Imaging Tumor Proliferation in ...... Predictive Imaging Biomarkers

@en

Imaging Tumor Proliferation in ...... Predictive Imaging Biomarkers

@nl

P1476

Imaging Tumor Proliferation in ...... Predictive Imaging Biomarkers

@en

P2093

Azadeh Elmi

http://www.w3.org/2001/XMLSchema#string

David Mankoff

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies

A systematic review on [(18)F]FLT-PET uptake as a measure of treatment response in cancer patients

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.

Cyclin D as a therapeutic target in cancer

Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer.

Selective estrogen receptor modulators: structure, function, and clinical use.

Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.

CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment.

Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer.

P304

445-457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CPET.2018.02.007

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

E S McDonald

P577

2018-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30100082

http://www.w3.org/2001/XMLSchema#string

P932

6092945

http://www.w3.org/2001/XMLSchema#string